BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10350015)

  • 1. The effect of collinearity on parameter estimates in nonlinear mixed effect models.
    Bonate PL
    Pharm Res; 1999 May; 16(5):709-17. PubMed ID: 10350015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of an iterative two-stage bayesian technique for population pharmacokinetic analysis of rich data sets.
    Proost JH; Eleveld DJ
    Pharm Res; 2006 Dec; 23(12):2748-59. PubMed ID: 17089202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of correlation on covariate selection in linear and nonlinear mixed effect models.
    Bonate PL
    Pharm Stat; 2017 Jan; 16(1):45-54. PubMed ID: 27580760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.
    Retout S; Mentré F
    J Biopharm Stat; 2003 May; 13(2):209-27. PubMed ID: 12729390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regression.
    Ernest CS; Hooker AC; Karlsson MO
    Pharm Res; 2010 May; 27(5):866-77. PubMed ID: 20221897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.
    Savic RM; Mentré F; Lavielle M
    AAPS J; 2011 Mar; 13(1):44-53. PubMed ID: 21063925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of type I error rates when modeling ordered categorical data in NONMEM.
    Wählby U; Matolcsi K; Karlsson MO; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2004 Feb; 31(1):61-74. PubMed ID: 15346852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
    Kjellsson MC; Jönsson S; Karlsson MO
    AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
    Ling J; Qian LX; Ding JJ; Jiao Z
    Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.
    Sun H; Ette EI; Ludden TM
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):637-50. PubMed ID: 9300354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM.
    Langdon G; Gueorguieva I; Aarons L; Karlsson M
    Eur J Clin Pharmacol; 2007 May; 63(5):485-98. PubMed ID: 17345074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analyses.
    Bonate PL
    J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):101-15. PubMed ID: 23288469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated covariate model building within NONMEM.
    Jonsson EN; Karlsson MO
    Pharm Res; 1998 Sep; 15(9):1463-8. PubMed ID: 9755901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo simulation of parameter confidence intervals for non-linear regression analysis of biological data using Microsoft Excel.
    Lambert RJ; Mytilinaios I; Maitland L; Brown AM
    Comput Methods Programs Biomed; 2012 Aug; 107(2):155-63. PubMed ID: 21764476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
    Tod M; Aouimer A; Petitjean O
    Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
    Baverel PG; Savic RM; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.